Most of us define our health as above average.
Yet, 97% live with everyday health issues such as e.g. stress, sleep issues and digestive problems*.
Imagine how great life would be if we didn’t have to live with such issues.
So let’s decide not to.
Karo Pharma delivers smart choices that give people control over their everyday healthcare.
*IPSOS “Self Care: Be Your Best” Report, 2019
“The itching has been going for so long, I was starting to accept that this was just my skin.”
– Male, Norway
Probiotics: The natural way to boost your wellbeing
“I noticed my hemorrhoids as an early teen, but didn’t do anything about it for years.”
– Male, UK
“The cortisone cream was a game changer for me. I felt the difference immediately.”
– Male, Norway
1 out of 5 adults live with toenail fungus
– Global Nail Fungus Organization 2019
“We’ve made it our purpose to develop reliable ways for people to treat their everyday ailments, to help them live healthier lives. We call it smart choices for everyday healthcare.”
Christoffer Lorenzen, CEO, Karo Pharma
Press releases
Karo Pharma completes the acquisition of the brand portfolio from Teva Pharmaceuticals
Karo Pharma Aktiebolag (“Karo”) today announces that the acquisition of the European OTC brand portfolio from Teva Pharmaceuticals (Teva) for…
Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals
Karo Pharma Aktiebolag (“Karo”) today announces the acquisition of an OTC brand portfolio containing Flux®, Decubal®, Lactocare®, Apobase®, Dailycare® and…
Karo Pharma AB divests its Hospital Supply business, Swereco AB, to J2L Holding AB
As previously announced, Karo Pharma AB (“Karo Pharma”) has carried out a strategic evaluation of the Hospital Supply business unit,…
Reports
Karo Pharma publishes the 2020 annual report
Today, on 30 March 2021, Karo Pharma is publishing its annual report for 2020 on the company’s website, www.karopharma.com. For…
Year-end report 2020
Q4, October – December Net sales amounted to MSEK 721.2 (649.3). This corresponds to an increase of 11% for the…
Karo Pharma publishes third-quarter report 2020 and resolves on sale of own shares
Q3, July – September Net sales amounted to MSEK 679.1 (443.7). This corresponds to an increase of 53% for the…
We support Operation Smile
Every three minutes, a child with cleft lip or palate is born. These children often live a tough life, having to endure harassment and isolation.
Operation Smile perform about 15,000 surgeries a year – improving the lives of just as many children all over the world. For us this is a smart choice for everyday healthcare and why Karo Pharma has supported Operation Smile since 2018.
You can read more about the medical missions in Malawi, Mozambique and Ghana, which our backing made possible, in our Annual Report.